Brainstorm Cell Therapeutics Inc. (BCLI)
USD 2.25
(25.7%)
USD 2.25
(25.7%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | -366 Thousand | - |
| Cost of Revenue | 265 Thousand | 285 Thousand | 260 Thousand | 219 Thousand | 366 Thousand | 110 Thousand |
| Gross Profit | -265 Thousand | -285 Thousand | -260 Thousand | -219 Thousand | -732 Thousand | -110 Thousand |
| Operating Expenses | 21.17 Million | 24.82 Million | 24.53 Million | 31.68 Million | 23 Million | 14.06 Million |
| Selling, General and Administrative Expenses | 10.69 Million | 10.86 Million | 9.3 Million | 9.35 Million | 5.79 Million | 5.77 Million |
| Research and Development Expenses | 10.48 Million | 13.95 Million | 15.23 Million | 22.32 Million | 17.2 Million | 8.29 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 21.43 Million | 24.82 Million | 24.53 Million | 31.68 Million | 23 Million | 14.06 Million |
| Operating Income | -21.43 Million | -24.82 Million | -24.53 Million | -31.68 Million | -23 Million | -14.06 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -545 Thousand | -82 Thousand | 127 Thousand | 252 Thousand | -115 Thousand |
| Earnings before Tax | -17.19 Million | -24.27 Million | -24.45 Million | -31.81 Million | -23.25 Million | -13.94 Million |
| Net Income | -17.19 Million | -23.73 Million | -24.37 Million | -31.93 Million | -23.5 Million | -13.83 Million |
| Earnings Per Share Basic | -0.40 | -0.65 | -0.67 | -1.07 | -1.07 | -0.69 |
| Earnings Per Share Diluted | -0.40 | -0.65 | -0.67 | -1.07 | -1.07 | -0.69 |
| Weighted Average Shares Outstanding | 42.98 Million | 36.5 Million | 36.18 Million | 29.84 Million | 21.9 Million | 19.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 43.07 Million | 36.5 Million | 36.18 Million | 29.84 Million | 21.9 Million | 19.99 Million |
| Gross Margin | - | - | - | - | 2.00 | - |
| EBIT Margin | - | - | - | - | 62.40 | - |
| Profit Margin | - | - | - | - | 64.22 | - |
| EBITDA | -16.92 Million | -23.99 Million | -24.27 Million | -31.46 Million | -23.08 Million | -13.83 Million |
| Earnings Before Tax Margin | - | - | - | - | 62.84 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 365 Thousand | -569 Thousand | 343 Thousand | - | - | 154 Thousand |
| Cost of Revenue | 64 Thousand | 64 Thousand | 66 Thousand | 265 Thousand | 65 Thousand | 67 Thousand |
| Gross Profit | 301 Thousand | -633 Thousand | 277 Thousand | -265 Thousand | -65 Thousand | 87 Thousand |
| Operating Expenses | 2.91 Million | 2.41 Million | 4.73 Million | 21.17 Million | 6.03 Million | 5.44 Million |
| Selling, General and Administrative Expenses | 2.06 Million | 1.51 Million | 3.1 Million | - | 2.7 Million | 2.65 Million |
| Research and Development Expenses | 858 Thousand | 897 Thousand | 1.63 Million | - | 3.33 Million | 2.79 Million |
| Other Expenses | -2.9 Million | - | - | - | - | - |
| Cost and Expenses | 2.98 Million | 2.47 Million | 4.8 Million | 21.43 Million | 6.03 Million | 5.44 Million |
| Operating Income | -2.98 Million | -2.47 Million | -4.8 Million | -21.43 Million | -6.03 Million | -5.44 Million |
| Interest Expense | - | - | 92 Thousand | - | - | - |
| Income Tax Expense | - | 20.72 Thousand | 4.96 Million | - | -4.87 Million | -55.08 Thousand |
| Earnings before Tax | -2.54 Million | -3.4 Million | -5.57 Million | -17.19 Million | -1.22 Million | -5.32 Million |
| Net Income | -2.54 Million | -3.4 Million | -5.57 Million | -17.19 Million | -1.22 Million | -5.32 Million |
| Earnings Per Share Basic | -0.04 | -0.05 | -0.11 | - | -0.03 | -0.13 |
| Earnings Per Share Diluted | -0.04 | -0.05 | -0.11 | - | -0.03 | -0.13 |
| Weighted Average Shares Outstanding | 71.21 Million | 64.73 Million | 50.43 Million | 43.07 Million | 44.25 Million | 39.69 Million |
| Weighted Average Shares Outstanding (Diluted) | 71.21 Million | 64.73 Million | 50.43 Million | 43.07 Million | 44.25 Million | 39.69 Million |
| Gross Margin | 0.82 | 1.11 | 0.81 | - | - | 0.56 |
| EBIT Margin | -7.99 | 4.24 | -13.81 | - | - | -34.95 |
| Profit Margin | -6.96 | 5.98 | -16.26 | - | - | -34.60 |
| EBITDA | -2.91 Million | -2.41 Million | -4.73 Million | - | -10.96 Million | -5.38 Million |
| Earnings Before Tax Margin | -8.17 | 4.35 | -14.01 | - | - | -35.38 |
4722
SAM
3622
2548
0QQ0
NIMBSPROJ